Azorsa DO - Search Results

1

Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis.

Azorsa DO, Lee DW, Wai DH, Bista R, Patel AR, Aleem E, Henry MM, Arceci RJ. Azorsa DO, et al. Pediatr Blood Cancer. 2018 Sep;65(9):e27237. doi: 10.1002/pbc.27237. Epub 2018 May 16. Pediatr Blood Cancer. 2018. PMID: 29768711

2

In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells.

Montoya JJ, Turnidge MA, Wai DH, Patel AR, Lee DW, Gokhale V, Hurley LH, Arceci RJ, Wetmore C, Azorsa DO. Montoya JJ, et al. Among authors: azorsa do. BMC Cancer. 2019 Dec 27;19(1):1251. doi: 10.1186/s12885-019-6464-9. BMC Cancer. 2019. PMID: 31881855 Free PMC article.

3

Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.

Bista R, Lee DW, Pepper OB, Azorsa DO, Arceci RJ, Aleem E. Bista R, et al. Among authors: azorsa do. J Exp Clin Cancer Res. 2017 Feb 1;36(1):22. doi: 10.1186/s13046-017-0493-5. J Exp Clin Cancer Res. 2017. PMID: 28143565 Free PMC article.

4

BIRC5 expression is a poor prognostic marker in Ewing sarcoma.

Hingorani P, Dickman P, Garcia-Filion P, White-Collins A, Kolb EA, Azorsa DO. Hingorani P, et al. Among authors: azorsa do. Pediatr Blood Cancer. 2013 Jan;60(1):35-40. doi: 10.1002/pbc.24290. Epub 2012 Sep 7. Pediatr Blood Cancer. 2013. PMID: 22961763

5

Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6.

Tiedemann RE, Zhu YX, Schmidt J, Yin H, Shi CX, Que Q, Basu G, Azorsa D, Perkins LM, Braggio E, Fonseca R, Bergsagel PL, Mousses S, Stewart AK. Tiedemann RE, et al. Blood. 2010 Feb 25;115(8):1594-604. doi: 10.1182/blood-2009-09-243980. Epub 2009 Dec 7. Blood. 2010. PMID: 19996089 Free PMC article.

6

Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer.

Byron SA, Min E, Thal TS, Hostetter G, Watanabe AT, Azorsa DO, Little TH, Tapia C, Kim S. Byron SA, et al. Among authors: azorsa do. PLoS One. 2012;7(10):e46823. doi: 10.1371/journal.pone.0046823. Epub 2012 Oct 4. PLoS One. 2012. PMID: 23056468 Free PMC article.

7

Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies.

Azorsa DO, Bode PK, Wachtel M, Cheuk ATC, Meltzer PS, Vokuhl C, Camenisch U, Khov HL, Bode B, Schäfer BW, Khan J. Azorsa DO, et al. Mod Pathol. 2021 Apr;34(4):748-757. doi: 10.1038/s41379-020-00719-0. Epub 2020 Dec 9. Mod Pathol. 2021. PMID: 33299109 Free PMC article.

8

Optimization of Transfection Conditions for siRNA Screening.

Montoya JJ, Azorsa DO. Montoya JJ, et al. Among authors: azorsa do. Methods Mol Biol. 2016;1470:15-24. doi: 10.1007/978-1-4939-6337-9_2. Methods Mol Biol. 2016. PMID: 27581281

9

Data Analysis for High-Throughput RNAi Screening.

Azorsa DO, Turnidge MA, Arora S. Azorsa DO, et al. Methods Mol Biol. 2016;1470:247-60. doi: 10.1007/978-1-4939-6337-9_19. Methods Mol Biol. 2016. PMID: 27581298

10

BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies.

Bogenberger JM, Kornblau SM, Pierceall WE, Lena R, Chow D, Shi CX, Mantei J, Ahmann G, Gonzales IM, Choudhary A, Valdez R, Camoriano J, Fauble V, Tiedemann RE, Qiu YH, Coombes KR, Cardone M, Braggio E, Yin H, Azorsa DO, Mesa RA, Stewart AK, Tibes R. Bogenberger JM, et al. Among authors: azorsa do. Leukemia. 2014 Aug;28(8):1657-65. doi: 10.1038/leu.2014.44. Epub 2014 Jan 23. Leukemia. 2014. PMID: 24451410 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters